| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | STF-62247 | GDSC1000 | pan-cancer | AAC | -0.088 | 0.01 |
| mRNA | STF-31 | CTRPv2 | pan-cancer | AAC | -0.093 | 0.01 |
| mRNA | FMK | GDSC1000 | pan-cancer | AAC | -0.098 | 0.01 |
| mRNA | tivozanib | GDSC1000 | pan-cancer | AAC | -0.091 | 0.01 |
| mRNA | CUDC-101 | GDSC1000 | pan-cancer | AAC | -0.082 | 0.01 |
| mRNA | BRD-K80183349 | CTRPv2 | pan-cancer | AAC | -0.084 | 0.01 |
| mRNA | ML006 | CTRPv2 | pan-cancer | AAC | -0.096 | 0.01 |
| mRNA | CGP-60474 | GDSC1000 | pan-cancer | AAC | 0.14 | 0.01 |
| mRNA | AZD6482 | GDSC1000 | pan-cancer | AAC | 0.083 | 0.01 |
| mRNA | NVP-ADW742 | CTRPv2 | pan-cancer | AAC | -0.089 | 0.01 |